Elsevier

Differentiation

Volume 42, Issue 1, October 1989, Pages 10-23
Differentiation

Isolation and characterization of a multipotent clone of human embryonal carcinoma cells

https://doi.org/10.1111/j.1432-0436.1989.tb00602.xGet rights and content

Abstract

Histopathological studies suggest that the stem cells of human teratomas may be classified into two major categories: nullipotent stem cells, and multipotent stem cells, capable both of self-renewal and differentiation into a wide range of somatic and extraembryonic cell types. We have isolated a multipotent stem cell clone from the human teratoma cell line GCT 27, and compared its properties to a nullipotent clone derived from the same strain. The multipotent clone GCT 27 X-1 gave rise to colonies of mixed cell morphology in vitro. Analysis of cell surface, cytostructural and extracellular matrix markers in GCT 27 X-1 cells showed that the stem cells of this line were very similar in phenotype to nullipotent cells. The two cell clones were predominantly hypotriploid, and contained several marker chromosomes in common. GCT 27 X-1 was feeder-cell-dependent for continuous growth in vitro; removal of the feeder layer resulted in differentiation of the stem cells into a variety of cell types, some with characteristics of extraembryonic endoderm, others showing neuronal properties. When transplanted into nude mice, GCT 27 X-1 cells gave rise to teratocarcinomas containing embryonal carcinoma stem cells, and many other cell types: yolk sac carcinoma cells; cells producing alphafetoprotein or human chorionic gonadotrophin; glandular, columnar, cuboidal, and squamous epithelium; primitive mesenchyme and cartilage; neuroectodermal cells. Nullipotent GCT 27 C-4 cells could form colonies in the absence of feeder layers, but multipotent GCT 27 X-1 cells could not. While a range of known growth factors and related substances failed to substitute for feeder layers in supporting the growth of GCT 27 X-1 stem cells, supernatants from yolk sac carcinoma cell line GCT 44 could partially replace the feeder cell requirement. Thus, the results revealed a basic difference in growth control between these multipotent and nullipotent human embryonal carcinoma cells, and suggested a possible paracrine regulatory pathway between multipotent stem cells and yolk sac carcinoma cells.

References (51)

  • LH Shevinsky et al.

    Monoclonal antibody to murine embryos defines a stage specific embryonic antigen expressed in mouse embryos and human teratocarcinoma cells

    Cell

    (1982)
  • AG Smith et al.

    Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells

    Dev Biol

    (1987)
  • J Smith et al.

    Dominance and independent segregation of metabolic cooperation-competence and pluripotency in an embryonal carcinoma cell hybrid

    Exp Cell Res

    (1989)
  • AWM Van der Kamp et al.

    Developmental characteristics of somatic cell hybrids between totipotent mouse teratocarcinoma and rat intestinal villus cells

    Exp Cell Res

    (1984)
  • GNP Van Muijen et al.

    Intermediate filaments in Merkel cell tumours

    Hum Path

    (1985)
  • U Wewer et al.

    Human laminin isolated in a nearly intact biologically active form from placenta by limited proteolysis

    J Biol Chem

    (1983)
  • SM Weima et al.

    Differentially regulated production of platelet-derived growth factor and of transforming growth factor beta by a human teratocarcinoma cell line

    Differentiation

    (1988)
  • PW Andrews et al.

    Immunochemistry of human teratocarcinoma stem cells

  • PW Andrews et al.

    Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2

    Lab Invest

    (1984)
  • C Biddle et al.

    Insulin-like growth factors and the multiplication of Tera-2, a human teratoma-derived cell line

    J Cell Sci

    (1988)
  • S Cooper et al.

    Vitronectin production by human yolk sac carcinoma cells resembling parietal endoderm

    Development

    (1988)
  • P Cowin et al.

    The complement of desmosomal plaque proteins in different cell types

    J Cell Biol

    (1985)
  • I Damjanov

    The pathology of human teratomas

  • E Debus et al.

    Monoclonal antibodies to desmin, the muscle-specific intermediate filament protein

    EMBO J

    (1983)
  • E Debus et al.

    Monoclonal antibodies specific for glial fibrillary acidic protein and for each of the neurofilament triplet polypeptides

    Differentiation

    (1983)
  • Cited by (0)

    View full text